GDNF and Huntington disease: Preclinical studies in rat models of HD have demonstrated the benefits of ICV injection of GDNF in restoring the excitotoxic-induced damage in the striatum, amelioration of amphetamine-induced rotational behavior (Araujo and Hilt, 1997) and locomotor activity improvement (Araujo and Hilt, 1998).